says Daniel Sørli.
yabeo and SHS invest in the leading Scandinavian digital health platform Dr. Dropin
27 April 22
● The fast-growing Norwegian healthcare provider Dr. Dropin enables short-term medical consultation and treatment – in person on-site as well as digitally via app
● Dr. Dropin posted revenue of more than 30m EUR in 2021, constituting a CAGR of more than 100% for the last three years
● Dr. Dropin posted revenue of more than 30m EUR in 2021, constituting a CAGR of more than 100% for the last three years
Munich / Oslo 22.04.2022
yabeo and the Tübingen-based investment company SHS invest together in Dr. Dropin, a digital and physical healthcare provider platform for medical consultations – physically on-site at one of the Dr. Dropin clinics or in the form of a digital consultation via app.
In times of the corona pandemic, but also before, patients suffer from long waiting times until they get an appointment with a doctor. Independent it is an appointment with a general practitioner or a specialist – the waiting times are long, and the patient journeys are often challenging. Dr. Dropin would like to eliminate these difficulties with its bundle of clinics. Appointments are easily booked online via the company’s app. Patients should thus be able to be treated at short notice without long waiting times either in person or via digital consultation hours. Follow-up appointments can also take place easily within the digital setup.
In this way, Dr. Dropin combines the personal contact that is essential in medical consultations with the advantages digital products have, to make patients’ journeys easier in their everyday lives. As part of the investment strategy, Dr. Dropin wants, based on the success in Norway, to expand its services into other European countries.
“We are delighted to have SHS on board on our exciting journey towards internationalization and to have an investor with sector expertise and vision. Our goal is to make healthcare better and easily accessible to everyone,”
CEO Dr. Dropin
“We are always looking for innovative and disruptive health tech companies to invest in, and Dr. Dropin fits our profile well. With the growth and development shown by Dr. Dropin and their highly dedicated team so far, combined with our goal of investing in companies that are game-changers within their industry, we believe this transaction will contribute to Dr. Dropin’s competitive growth when entering the European markets.”
Dr. Gerrit Seidel
Managing Director, and Partner at yabeo
“SHS is pleased to be able to support a company like Dr. Dropin. Nowadays, a straightforward and fully comprehensive medical offer with the possibility of digital consultation is essential. We think that Dr. Dropin’s “Digi-physical” concept fills a promising gap in the market, and we are pleased to be able to support the company with our know-how and many years of experience in the healthcare sector. We are always seeking promising companies that have the potential to become European healthcare champions like Dr. Dropin,”
explains SHS partner Dr. Cornelius Maas.
About Dr. Dropin:
The Norwegian healthcare provider Dr. Dropin was founded in 2017 by Dr. Daniel Sørli. The company offers general practitioners, specialists, physiotherapists, and psychologists at fixed prices with short waiting times. The company has 25 clinics in all major Norwegian cities and offers most of its services via secure digital solutions. The company’s largest shareholders are the start-up Askeladden & Co and the founder Dr. Daniel Sørli himself.
Further information at www.drdropin.no.
More news